Patents by Inventor Amy H. Newman

Amy H. Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5668285
    Abstract: The invention involves a method of making key intermediates useful in the synthesis of many opiate narcotics and antagonists and agonists; and the non-opiate enantiomers thereof which have potent antitussive properties. The synthesis starts from either the natural or unnatural enantiomer of nordihydrocodeinone and produces 8, 14-dihydronorthebaine, the diketal of 7-bromonordihydrocodeinone, northebaine, norcodeinone diketal and 14-hydroxynorcodeinone intermediates without the necessity of leaving the N-nor structure. The syntheses have fewer steps than previous methods, and also have high yields.
    Type: Grant
    Filed: March 12, 1992
    Date of Patent: September 16, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Kenner C. Rice, Amy H. Newman
  • Patent number: 5331010
    Abstract: The compounds belong to the class of non-narcotic, non-opiate derivatives the 1-phenylalkanecarboxylic acid basic structure useful as anticonvulsant and neuroprotective agents. The compounds include novel derivatives as well as previously published species. Methods for controlling convulsions in a variety of pharmaceutical formulations and modalities are also provided.
    Type: Grant
    Filed: June 5, 1991
    Date of Patent: July 19, 1994
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Amy H. Newman, Silvia N. Calderon, Frank C. Tortella
  • Patent number: 5258386
    Abstract: It has been discovered that certain (+)-3-substituted-N-alkylmorphinans are ffective anticonvulsant and neuroprotective agents. Novel compounds having these biological properties are presented in a method of use for preventing, treating or controlling convulsions in mammals having a need for such treatment. The compounds do not lead to dependency, have low toxicity, and provide effective anticonvulsant or neuroprotective treatment with little or no behavioral detriment to the recipient. A number of pharmacological formulations and methods of administering compounds of the invention are suitable for anticonvulsive or neuroprotective treatments.
    Type: Grant
    Filed: June 5, 1991
    Date of Patent: November 2, 1993
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Amy H. Newman, Frank C. Tortella